Yunjie Zhao | Biological Networks | Research Excellence Award

Published on by Network Science

Prof. Yunjie Zhao | Biological Networks | Research Excellence Award

Central China Normal University | China

Prof. Yunjie Zhao is a distinguished biophysicist who earned his Ph.D. in Biophysics from Huazhong University of Science and Technology in 2012, where he conducted pioneering research on computational prediction of non-coding RNA structures under the mentorship of Prof. Yi Xiao, following his B.S. in Physics from the same institution. He advanced his expertise as a Postdoctoral Research Scientist at The George Washington University with Prof. Chen Zeng, contributing significantly to de novo protein design and bionetwork modeling. Since 2016, he has been a faculty member at Central China Normal University, becoming a full Professor in 2019, and has taught a wide range of courses including Machine Learning, Biophysics, Bioinformatics, Computational Biology, and Physics. Prof. Zhao is an active member of several professional societies, including the Chinese Physical Society and the Biophysical Society of China, and previously the American Physical Society. He serves as an editorial board member for leading journals such as Briefings in Bioinformatics, iScience, Pharmaceuticals, Life, Biomolecules, International Journal of Molecular Sciences, and Scientific Reports, and is a frequent reviewer for top-tier publications including Nature Biotechnology, Nature Reviews Genetics, Nature Machine Intelligence, Nature Communications, and Physical Review Letters. His research contributions are further reflected in multiple granted patents spanning protein–ligand binding site prediction, RNA contact prediction, plant lectin polymerization peptide inhibitors, and protein drug binding pocket prediction, underscoring his impactful contributions to computational biology and biophysics.

Profiles: Scopus | Google Scholar

Featured Publications

"RNA-protein interaction prediction using network-guided deep learning", H Liu, Y Jian, C Zeng, Y Zhao, Communications Biology 8 (1), 2025.

"Advances and Mechanisms of RNA–Ligand Interaction Predictions", C Zhuo, C Zeng, H Liu, H Wang, Y Peng, Y Zhao Life 15 (1), 2025.

"Decoding the effects of mutation on protein interactions using machine learning", W Xu, A Li, Y Zhao, Y Peng, Biophysics Reviews 6 (1), 2025.

"Advances in Methods for Accurate Prediction of RNA–Small Molecule Binding Sites: From Isolated to AI-Integrated Strategies", J Gao, C Zhuo, C Zeng, H Liu, Y Zhao, Pharmaceuticals 18 (10), 2025.

"Ab initio HIV-1 Tat–TAR interactions study using hybrid scoring-enhanced molecular modeling across subtypes", C Zeng, H Wang, J Gao, H Liu, C Zhuo, Y Zhao, Physical Chemistry Chemical Physics 27 (27), 2025.

Yingzi Yang | Biological Networks | Research Excellence Award

Published on by Network Science

Prof. Yingzi Yang | Biological Networks | Research Excellence Award

Harvard School of Dental Medicine | United States

Prof. Yingzi Yang is a distinguished developmental biologist whose career spans leading institutions including Harvard Medical School and the National Institutes of Health. She earned her BS in Biology from Fudan University in 1988 and completed her PhD in Molecular Biology at the Sloan-Kettering Institute and Weill Medical College of Cornell University in 1996, followed by postdoctoral training with Andrew P. McMahon at Harvard University. She joined the NIH in 2000 as an Investigator and rose to Senior Investigator before being appointed Professor of Developmental Biology at Harvard Medical School in 2015, where she also serves as Principal Faculty of the Harvard Stem Cell Institute and a member of the Dana-Farber/Harvard Cancer Center. Widely recognized for her contributions to Wnt signaling, skeletal biology, and developmental mechanisms, Prof. Yang has received numerous honors including the AAAS Fellowship, ASBMR Fellowship, the IADR Distinguished Scientist Award, multiple NIH Awards of Merit, and the Vincent du Vigneaud Award of Excellence. She has held major leadership roles such as President of the Chinese Biological Investigators Society (2022–2024), member of the NIH SBDD Study Section, and keynote speaker at national scientific meetings. Her extensive service includes high-level Harvard committees, NIH central tenure committees, Gordon Research Conference leadership, international symposium organization, and major grant review panels for NIH, NSF, and global scientific agencies. A respected scholar and reviewer for top-tier journals including Cell, Nature family journals, Science family journals, and Development, Prof. Yang is recognized worldwide for advancing fundamental understanding of developmental and stem cell biology and their implications for human disease.

Profiles: Scopus | Google Scholar

Featured Publications

"Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation", Y Liu, J Zhu, Y Jin, Z Sun, X Wu, H Zhou, Y Yang, Nature Communications 16 (1), 2025.

"Fibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research", B Palmisano, C Berry, A Boyce, JF Charles, MT Collins, A Corsi, FA Fierro, Orphanet Journal of Rare Diseases 20 (1), 2025.

"Piezo1-mediated mechanotransduction controls osteocyte maturation and dendrite development via a YAP-CCN-Src signaling axis", YJ Hu, X Wu, F Wang, Y Jin, Y Jin, Y Liu, Q Cong, Y Yang, Nature Communications, 2025.

"Injury-induced niche factors Cxcl12 and Shh/Ihh coordinate suture stem cell activation during calvarial bone regeneration", B Li, T Ouchi, J Liu, Y Yang, Science Signaling 18 (909), 2025.

"Neutralization of Receptor activator of nuclear factor-κB ligand reduces fibrosis and promotes osteoblast differentiation in a mouse model of fibrous dysplasia driven", RT Ormsby, Y Zhang, C Hodys, LA Wake, SM Perez, K Tsang, Y Yang, JBMR plus 9 (10), 2025.

Peter Ikechukwu Nwaichi | Technological Innovation | Best Researcher Award

Published on by Network Science

Dr. Peter Ikechukwu Nwaichi | Technological Innovation | Best Researcher Award

University of Malaysia, Pahang | Malaysia

Dr. Peter Ikechukwu Nwaichi is an accomplished professional with an MSc in Safety, Health, and Environment from Universiti Teknologi Malaysia and a PhD (in view), bringing strong academic depth to his diverse technical expertise. His research interests span Risk Assessment and Risk Management, Oil Well Analysis, Data Analysis, and Waste Management, reflecting a commitment to advancing safety and operational efficiency within industrial environments. Dr. Nwaichi has gained extensive hands-on experience through his work with Weafri Well Services Company, where he contributed to cementing, pumping, corrosion control, and coiled tubing operations. He has also served in key roles at ACM of Nigeria as a Safety Officer, Material Coordinator, and Designer, demonstrating versatility and a strong track record in ensuring safe, efficient, and sustainable work processes across the energy and industrial sectors.

Profiles: Google Scholar

Featured Publications

"Numerical simulation of microbial biohydrogen production under high-pressure, high-temperature conditions for enhanced recovery from depleted reservoirs", D Abutu, PI Nwaichi, C Umunnawuike, F Nyah, B Money, HW Yussof, Petroleum Research, 2025

"Nanoparticles transport in porous media during EOR operations: A Wide-Ranging review of mechanisms, mathematical models, influencing parameters, challenges, and prospects", EN Ngouangna, IB Dzulkarnain, MZ Jaafar, JO Oseh, FA Afolabi, Arabian Journal for Science and Engineering, 2025.

"Biohydrogen production for sustainable energy transition: a bibliometric and systematic review of the reaction mechanisms, challenges, knowledge gaps and emerging trends", C Umunnawuike, SQA Mahat, PI Nwaichi, B Money, A Agi Biomass and bioenergy, 2024.

"Recent advances and prospects on retarder application in oilwell cement: A review", PI Nwaichi, N Ridzuan, EO Nwaichi, C Umunnawuike, A Agi Geoenergy Science and Engineering 241, 2024.

"Comprehensive review on the role of salinity on oil recovery mechanisms during chemical flooding", F Nyah, N Ridzuan, PI Nwaichi, C Umunnawuike, A Agi Journal of Molecular Liquids 415, 2024.

Probal Banerjee | Biological Network | Best Researcher Award

Published on by Network Science

Dr. Probal Banerjee | Biological Network | Best Researcher Award

The College of Staten Island (City University of New York) | United States

Dr. Probal Banerjee is a distinguished biochemist and neuroscientist whose academic and research career spans over four decades of excellence in bioorganic chemistry, molecular neuroscience, and cancer research. He earned his B.Sc. in Chemistry (Hons) and M.Sc. in Organic Chemistry from Jadavpur University, Calcutta, followed by a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore in 1984. He completed postdoctoral research at the University of Notre Dame in Biochemistry and Enzymology and at the University of Chicago in Molecular Neuroscience. Currently a Professor of Chemistry and Coordinator at the Center for Developmental Neuroscience, College of Staten Island, CUNY, Dr. Banerjee has made pioneering contributions to understanding neurodevelopmental signaling and immune-modulating cancer therapies. His numerous honors include the Children’s Research Foundation Grant (1989), Brain Research Foundation Award, and two Dolphin Awards for Academic Excellence and Teaching. A sought-after speaker, he has delivered invited lectures at leading institutions worldwide on topics ranging from serotonin signaling in brain development to multi-target cancer therapeutics. Dr. Banerjee is also an inventor with several patents on curcumin-based anticancer agents and therapeutic approaches for Fragile X Syndrome. His expertise is widely recognized through his service on multiple NIH grant review committees, reflecting his enduring impact on neuroscience, pharmacology, and translational cancer research.

Profiles: Orcid 

Featured Publications

"Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions", Shubhasmita Mohapatra; Adrian Guerrero; Neha Rahman; Khondoker Takia Zaman; Jing Wu; Callistus Onyeagba; Chanyue Hu; Matteo Pellegrini; Jayaram Vankudoth; Seiya Kitamura et al., Cells, 2025.

"One-Pot Synthesis of Phenylboronic Acid-Based Microgels for Tunable Gate of Glucose-Responsive Insulin Release at Physiological pH", Prashun G. Roy; Jiangtao Zhang; Koushik Bhattacharya; Probal Banerjee; Jing Shen; Shuiqin Zhou, Molecules, 2025.

"Biocompatible Anisole-Nonlinear PEG Core–Shell Nanogels for High Loading Capacity, Excellent Stability, and Controlled Release of Curcumin", Jing Shen; Jiangtao Zhang; Weitai Wu; Probal Banerjee; Shuiqin Zhou, Gels 2023.

"The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus", Sreyashi Samaddar; Sudarshana Purkayastha; Souleymane Diallo; Subramanyam J. Tantry; Ryan Schroder; Pranavan Chanthrakumar; Michael J. Flory; Probal Banerjee, International Journal of Molecular Sciences 2022.

"Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells", Sumit Mukherjee; Angela Fried; Rahman Hussaini; Richard White; Juliet Baidoo; Sri Yalamanchi; Probal Banerjee, Journal of Experimental & Clinical Cancer Research, 2018.

Milton Mondal | Mathematical Modelling | Best Researcher Award

Published on by Network Science

Dr. Milton Mondal | Mathematical Modelling | Best Researcher Award

Amrita Vishwa Vidyapeetham, Coimbatore | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Dynamics of a phytoplankton–zooplankton model with three-dimensional patch under the impacts of hydrodynamic conditions", M Mondal, CS Rao, T Zhang, Mathematics and Computers in Simulation, 2025.

"Bloom dynamics under the effects of periodic driving forces", M Mondal, T Zhang, Mathematical Biosciences, 2025.

"Mathematical Modelling and Analysis of Harmful Algal Bloom", M Mondal, Bulletin of the Australian Mathematical Society, 2024.

Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Reliance Life Sciences Pvt Ltd | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Unveiling Lytic Bacteriophages as Promising Biotherapeutics for the Control of Multidrug-Resistant Pseudomonas aeruginosa", CS Nikhil Sathe, Eugene Athan, Arnab Kapat, BioMed, 2025.

"Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus", N Sathe, S Shaikh, M Bhavsar, L Parte, A Gadiparthi, S Kad, S Sensarma, Vaccine, 2024.

"Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae-Unraveling efficacy through innovative", N Sathe, C Suphioglu, E Athan, A Kapat, Microbial Pathogenesis, 2024.

"Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment", N Sathe, P Beech, L Croft, C Suphioglu, A Kapat, E Athan, Infectious medicine 2, 2023.

"Development of a novel therapy using bacteriophages: An alternative to antibiotics", NS Sathe, Deakin University, 2023.

Eman Kamal Ahmed Abdelall | Biological Network | Best Researcher Award

Published on by Network Science

Dr. Eman Kamal Ahmed Abdelall | Biological Network | Best Researcher Award

Beni-Suef University | Egypt

Dr. Eman Kamal Ahmed Abdelall is a distinguished Professor of Pharmaceutical Organic Chemistry at Beni-Suef University, Egypt, with an outstanding academic and research career spanning over three decades. She earned her Ph.D. in Pharmaceutical Organic Chemistry from Cairo University in 2006 and has since advanced through academic ranks to become a full professor in 2018. Dr. Abdelall has held several key administrative positions, including Vice Dean of Student Affairs and Vice Dean for Environmental Affairs, and currently serves as the Head of the Department of Pharmaceutical Organic Chemistry. A prolific researcher, she has published over 53 peer-reviewed papers in leading journals indexed in Scopus and Google Scholar, with notable contributions to anti-inflammatory, anticancer, and antiviral drug design. Her excellence in scientific research has earned her numerous university honors, medals of excellence, and funded research awards. Dr. Abdelall is also an active reviewer for international journals, a member of higher education promotion committees, and a mentor who has supervised multiple Master’s and Doctoral theses, making her a leading figure in Egypt’s pharmaceutical research community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Molecular docking, ADME study, Cardiovascular biomarkers and gastric safety of new pyrazoles as selective anti-inflammatory agents", EKA Abdelall, SS Zaghlool, JZF Saad, JN Philoppes, Journal of Molecular Structur, 2025.

"Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities", EKA Abdelall, HAH Elshemy, MB Labib, JN Philoppes, FEM Ali, Bioorganic Chemistry, 2025.

"Synthesis and in silico studies of Novel thiophene–celecoxib hybrid with excellent cardiotoxicity and nephrotoxicity safety profiles", EKA Abdelall, PF Lamie, MB Labib, M El-Daly, A Mishrif, European Journal of Medicinal Chemistry, 2025.

"Novel quinoxaline derivatives as promising cytotoxic agents: structure-based design, in silico studies, VEGFR-2 inhibition, and PI3K/AKT/mTOR pathway modulation", EKA Abdelall, HAH Elshemy, H Abdelmegeed, N Ryad, AA Abdelaziz, Bioorganic Chemistr, 2025.

"The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya", ASH Alhomri, AA Battah, AA Elberry, EKA Abdelall, R Hussein", Pharmacy Practice, 2024.

Xiaosuo Wang | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Xiaosuo Wang | Technological Networks | Best Researcher Award

The University of Sydney | Australia

Dr. Xiaosuo Wang is a distinguished researcher specializing in mass spectrometry, metabolomics, lipidomics, and proteomics, with deep expertise in vascular biology and heart failure. She earned her PhD in Medicine from the University of Sydney in 2009, focusing on novel ELISA methods to detect oxidised apolipoproteins in cardiovascular disease, following a master’s degree in Physiology and Pharmacology from the University of New South Wales and a bachelor’s in Biomedical Engineering from the Fourth Military Medical University, China. Currently a Senior Research Fellow and Senior Lecturer at the University of Sydney’s Charles Perkins Centre, she leads pioneering projects in biomarker discovery, metabolic assays, and multi-omics platform development for applications in liver disease, heart failure, and population health. Her work integrates advanced mass spectrometry, lipidomics, and metabolomics workflows with translational innovations such as point-of-care assays and biosensor development. Previously, as a Metabolomics Research Scientist at the Victor Chang Cardiac Research Institute and Manager of the Bosch Mass Spectrometry Facility, she developed over 60 advanced LC-MS assays and supported a wide range of biological and clinical research. Dr. Wang’s prolific contributions include more than 40 peer-reviewed publications, numerous conference presentations, and significant advancements in analytical methodologies for precision medicine.

Profiles: Scopus | Orcid ID

Featured Publications

"Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry. Pharmaceuticals, Xiaosuo Wang; Wei Yi Lew; Yang Yang; Nan Zhang; Jiexun Bu; Zhentao Li; Michael Fitzpatrick; Paul Bonnitcha; David Sullivan; Wenpeng Zhang et al., 2025"

"The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF, Circulation Research, Yen Chin Koay; Bailey McIntosh; Yann Huey Ng; Yang Cao; Xiao Suo Wang; Yanchuang Han; Saki Tomita; Angela Yu Bai; Benjamin Hunter; Ashish Misra et al., 2025"

"Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF, JACC. Basic to translational science, O'Sullivan JF; Li M; Koay YC; Wang XS; Guglielmi G; Marques FZ; Nanayakkara S; Mariani J; Slaughter E; Kaye DM, 2024"

"The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease, Pathology, Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF, 2023"

"Destabilization of Atherosclerotic Plaque by Bilirubin Deficiency, Circulation Research, Weiyu Chen; Sergey Tumanov; Christopher P. Stanley; Stephanie M.Y. Kong; James Nadel; Niv Vigder; Darren L. Newington; Xiao Suo Wang; Louise L. Dunn; Roland Stocker, 2025"

Kumail Abbas | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Kumail Abbas | Technological Networks | Best Researcher Award

Chulalongkorn University | Thailand

Dr. Kumail Abbas is a veterinary scientist and researcher specializing in precision livestock farming, animal health, and welfare technologies. He is currently pursuing his Doctor of Philosophy in Veterinary Science and Technology at Chulalongkorn University, Thailand, where his doctoral research focuses on employing artificial intelligence to track and monitor dairy cow behaviour during the transition period to predict postpartum disorders. As a Visiting Researcher at the Bristol Vet School, University of Bristol, and University of Salford (UK), Dr. Abbas contributes to the British Dairy Cattle Welfare Strategy (2023–2028) through AI-based behavioural monitoring and data-driven welfare benchmarking. He holds a Master’s in Bioscience Technology from Chung Yuan Christian University, Taiwan, where he investigated the neurophysiological and toxicological effects of ractopamine in zebrafish models, and a Doctor of Veterinary Medicine (DVM) from the University of Veterinary and Animal Sciences, Lahore, Pakistan. His professional experience spans academia, industry, and farm management, including roles as Graduate Research Assistant at Chung Yuan Christian University, Product Information Officer at Prix Pharmaceutica (Pvt.) Ltd., and Assistant Farm Manager at Kasur Dairies Pvt. Ltd., where he developed strong expertise in animal reproduction, health management, and sustainable dairy operations. Dr. Abbas’s research integrates AI, deep learning, and animal behaviour analysis to promote sustainable livestock production. He has received multiple awards and grants, including the Second Century Fund (C2F) Doctoral Fellowship, the 90th Anniversary Ratchadaphisek Somphot Endowment Fund, and the Biotech Excellent Award for academic excellence. His work has been published in international journals and presented at global conferences, reflecting his commitment to advancing innovation in animal science, digital agriculture, and welfare-oriented livestock technologies.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Impacts of early postpartum behavioral patterns on the fertility and milk production of tropical dairy cows"

"Behavioral Adaptations in Tropical Dairy Cows: Insights into Calving Day Predictions"

"Ractopamine at the Center of Decades-Long Scientific and Legal Disputes: A Lesson on Benefits, Safety Issues, and Conflicts"

"Evaluation of Effects of Ractopamine on Cardiovascular, Respiratory, and Locomotory Physiology in Animal Model Zebrafish Larvae"

"Sex determination by CHD (Chromo helicase DNA binding) gene in local rock pigeons (Columba livia) from Lahore, Pakistan"

Orhan Özturan | Research | Best Researcher Award

Published on by Network Science

Prof Orhan Özturan | Research | Best Researcher Award

Bezmialem Vakif University | Turkey

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. Orhan Özturan, born in Gaziantep in 1961, displayed academic excellence from an early stage. After graduating from Private Adana College in 1978, he pursued medical education at Hacettepe University, later transferring to Erciyes University, Faculty of Medicine, where he graduated as the second-highest-ranked student. His strong foundation in medicine set the stage for his specialization and subsequent contributions to the field of otorhinolaryngology.

Professional Endeavors

Following his compulsory service in Sivas (1984–1986), Dr. Özturan specialized in Ear, Nose, and Throat (ENT) diseases at Istanbul University. His career trajectory advanced steadily, beginning as an ENT specialist at Adana SSK Hospital (1991–1993) and later transitioning to academia. His academic journey started at İnönü University, where he rose through the ranks from Assistant Professor (1993) to Associate Professor (1995) and Professor (2001). His leadership extended into key administrative positions, including department head roles and hospital executive responsibilities, reflecting both clinical and managerial expertise.

Contributions and Research Focus

Dr. Özturan’s research and clinical work span a wide range of ENT subspecialties, with particular emphasis on nasal congestion, sinusitis, functional and aesthetic nose surgeries, sleep apnea management, pediatric ENT conditions, hearing loss, cochlear implantation, vertigo, and laryngeal cancer. His professional interests also encompass advanced surgical interventions, including eardrum reconstruction, facial nerve surgeries, and salivary gland treatments. His global training in Australia, the USA, and Israel enhanced his expertise and broadened his research outlook.

Impact and Influence

As an internationally recognized figure, Dr. Özturan has contributed substantially to advancing otorhinolaryngology. With 251 publications in international journals and 79 in national outlets, his work reflects both breadth and depth. His active participation in 64 international and 224 national meetings demonstrates his role as a thought leader and mentor within the medical community. His administrative service-as Vice Rector, Ethics Committee Vice Chair, and Chair of the Academic Performance Monitoring Commission-illustrates his influence beyond the clinic, shaping institutional policies and academic growth.

Academic Citations

The academic impact of Dr. Özturan’s scholarship is demonstrated by his impressive citation metrics. As of August 8, 2025, his Google Scholar citation count stands at 5,066, with an h-index of 39 and an i10-index of 126. These figures not only reflect the consistent quality of his research but also his enduring influence in shaping scientific inquiry within ENT and allied fields.

Legacy and Future Contributions

Dr. Özturan’s legacy is defined by his dual commitment to clinical excellence and academic advancement. His pioneering work in nasal surgery, cochlear implants, and sleep apnea treatment has provided new pathways for therapeutic intervention. As a mentor and leader, he has guided students, researchers, and practitioners, ensuring the continuity of high standards in medical education and practice. Looking ahead, his ongoing involvement at Bezmialem Vakif University positions him to continue shaping ENT research and medical education, inspiring future generations of otorhinolaryngologists.

Conclusion

In sum, Dr. Orhan Özturan’s career reflects a rare combination of clinical expertise, research productivity, and academic leadership. His early academic brilliance matured into a distinguished professional life marked by innovation, international collaboration, and scholarly impact. With a strong legacy already established, his future contributions are poised to further strengthen the global discourse in otorhinolaryngology, making him a worthy candidate for recognition as a leading researcher in his field.

Notable Publications

“Effect of Medical Ozone Therapy in Preventing Compromised Nasal Skin in Revision Rhinoplasty" 

  • Author: A Alp, E Polat, A Yenigun, O Pasin, O Ozturan
  • Journal: Aesthetic Plastic Surgery
  • Year: 2025

“Radiologic prevalence of otic capsule dehiscence and development of the Yenigun classification for semicircular canal dehiscence" 

  • Author: A Yenigun, YB Polat, E Polat, S Balsak, M Basoz, SB Eren, O Ozturan
  • Journal: Auris Nasus Larynx
  • Year: 2025

“Intranasal Diclofenac Sodium, Ibuprofen and Paracetamol for Pain Relief After Pediatric Tonsillectomy" 

  • Author: A Yenigün, RB Küçük, MF Özgan, H Uysal, AA Sağıroğlu, VB YENİGÜN
  • Journal: International Journal of Pediatric Otorhinolaryngology
  • Year: 2025

“Enhancing Nasal Tip Projection and Stability with a Columellar Strut Graft Placed in a Mucosal Flap Pocket" 

  • Author: M Ceran, A Yenigun, E Polat, O Ozturan
  • Journal: JPRAS Open
  • Year: 2025

“Spectral resolution and speech comprehension performance in noise in individuals with multiple sclerosis" 

  • Author: ÖG Toker, E Kuru, N Tas Elibol, V Güzel, R Doğan, O Özturan
  • Journal: BMC neurology
  • Year: 2025